A new study convincingly demonstrates a deficiency of pituitary oxytocin secretion in patients with vasopressin deficiency. Neuropsychological evaluations of these patients indicate increased anxiety and reduced prosocial behaviours, thereby characterizing the phenotype of the first documented disorder of oxytocin deficiency in humans.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Leng, G., Leng, R. I. & Ludwig, M. Oxytocin-a social peptide? Deconstructing the evidence. Phil. Trans. R. Soc. Lond. B 377, 20210055 (2022).
Sailer, C. O. et al. Oxytocin levels in response to pituitary provocation tests in healthy volunteers. Eur. J. Endocrinol. 185, 355–364 (2021).
Atila, C. et al. Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial. Lancet Diabetes Endocrinol. 11, 454–464 (2023).
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H. & Jacob, S. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinol. 46, 23–31 (2014).
Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S. & de Wit, H. Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacol. 39, 1654–1663 (2014).
Tabak, B. A. et al. Advances in human oxytocin measurement: challenges and proposed solutions. Mol. Psychiatry 28, 127–140 (2023).
Brown, C. H., Ludwig, M., Tasker, J. G. & Stern, J. E. Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation. J. Neuroendocrinol. 32, e12856 (2020).
Zhang, B. et al. Reconstruction of the hypothalamo-neurohypophysial system and functional dissection of magnocellular oxytocin neurons in the brain. Neuron 109, 331–346.e7 (2021).
Olson, B. R., Hoffman, G. E., Sved, A. F., Stricker, E. M. & Verbalis, J. G. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex. Brain Res. 569, 238–248 (1992).
Miaskiewicz, S. L., Stricker, E. M. & Verbalis, J. G. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans. J. Clin. Endocrinol. Metab. 68, 837–843 (1989).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verbalis, J.G. Oxytocin deficiency — a ‘new’ human disorder?. Nat Rev Endocrinol 19, 505–506 (2023). https://doi.org/10.1038/s41574-023-00870-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-023-00870-z
This article is cited by
-
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency
Nature Reviews Endocrinology (2024)